Alpha generation from sector specialized insights and disciplined portfolio construction

The Flagship Fund is an US-domiciled sector specialist fund which invests exclusively in private and public biotech companies (small and micro-cap US exchange traded companies)

• Pursue a fundamental bottom-up absolute-return strategy
• Constructing a portfolio of concentrated, conviction-driven positions with an average of 3-year hold periods in both the public and private sleeves
• Capture value in portfolio companies from correctly calling out clinical trial readouts.

The investment strategy marries the best elements of risk/return profiles in liquid and illiquid asset categories

• Generate alpha as a sector specialized fund, uncorrelated to the broader market, through consistent returns by picking the right side of the binary outcomes typical in biotech.
• Avoid returns dependent on outlier investing, or long illiquidity windows, typically seen in venture asset class.
• Do Not play both sides of a trade as a long/short hedge fund incentivized to “beat the index”.